학술논문

Methods to analyse epicardial mapping signals for the electrophysiological detection of viability in chronic ischemic myocardium
Document Type
Conference
Source
Proceedings of the 20th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. Vol.20 Biomedical Engineering Towards the Year 2000 and Beyond (Cat. No.98CH36286) Engineering in medicine and biology 1998 Engineering in Medicine and Biology Society, 1998. Proceedings of the 20th Annual International Conference of the IEEE. :63-66 vol.1 1998
Subject
Bioengineering
Signal analysis
Signal mapping
Myocardium
Electrodes
Surgery
Software tools
Automatic testing
Algorithm design and analysis
Frequency
Time domain analysis
Language
ISSN
1094-687X
Abstract
Epicardial mapping signals, acquired during bypass surgery, were analyzed to validate the electrophysiological detection of dysfunctional, but viable myocardium. This intraoperative epicardial mapping was performed with a sock electrode, including 102 bipolar leads. The signals were recorded, using a commercial mapping system, and analysed by custom made software tools. We developed and tested algorithms for the automated analysis of the local activation signals, to find changes in characteristic signal parameters for myocardial regions with disturbed contractility. Maximal amplitudes, activation onset and offset and the frequency content were calculated. Results of signal analysis were compared to expert analysis of the preoperative left ventricular angiogram, according to the epicardial grid of the mapping electrode, 1241 myocardial regions were classified in 17 patients, 131 as hypokinetic, 107 as akinetic and 31 as dyskinetic. The developed methods for signal analysis are feasible to determine characteristic time domain parameters in bipolar epicardial electrograms; significant differences of local amplitudes, activation markers and power distribution between regions with different contractility could be observed. These findings are of potential value for the electrophysiological identification of functionally impaired but viable myocardium in patients with chronic ischemic heart disease.